Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Micol Rothman

Concepts (205)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Osteoporosis
10
2023
239
3.770
Why?
Transgender Persons
8
2026
213
3.310
Why?
Osteoporotic Fractures
5
2024
62
2.380
Why?
Transsexualism
3
2026
21
2.180
Why?
Bone Density Conservation Agents
9
2024
82
2.130
Why?
Estradiol
5
2025
517
1.250
Why?
Absorptiometry, Photon
5
2023
276
1.230
Why?
Bone Density
6
2022
492
1.000
Why?
Bone Diseases, Metabolic
3
2024
59
0.990
Why?
Hyperandrogenism
2
2021
25
0.970
Why?
Hormone Replacement Therapy
1
2026
107
0.890
Why?
Testosterone
6
2025
419
0.830
Why?
Postmenopause
4
2021
394
0.710
Why?
Interdisciplinary Placement
1
2020
2
0.630
Why?
Videoconferencing
1
2020
62
0.600
Why?
Telecommunications
1
2019
19
0.590
Why?
Education, Medical, Continuing
1
2020
130
0.570
Why?
Practice Guidelines as Topic
2
2019
1581
0.570
Why?
Sexual and Gender Minorities
1
2023
268
0.570
Why?
Clinical Decision-Making
1
2019
364
0.460
Why?
Diphosphonates
2
2019
67
0.450
Why?
Pneumonia, Viral
1
2020
387
0.430
Why?
Coronavirus Infections
1
2020
379
0.430
Why?
Hypogonadism
3
2013
89
0.430
Why?
Quality Improvement
1
2023
1325
0.420
Why?
Denosumab
3
2024
10
0.410
Why?
Mass Media
1
2014
36
0.410
Why?
Glucocorticoids
3
2024
536
0.400
Why?
Osteoporosis, Postmenopausal
2
2024
41
0.380
Why?
Estrone
2
2010
41
0.350
Why?
Humans
39
2026
145625
0.350
Why?
Spinal Fractures
2
2024
81
0.340
Why?
Antiretroviral Therapy, Highly Active
1
2012
278
0.330
Why?
Fibrous Dysplasia, Polyostotic
1
2010
6
0.320
Why?
Dihydrotestosterone
1
2010
40
0.320
Why?
Telemedicine
1
2020
956
0.320
Why?
Polycystic Ovary Syndrome
1
2013
190
0.320
Why?
Facial Bones
1
2010
28
0.320
Why?
Mass Screening
2
2021
1300
0.320
Why?
Injections, Subcutaneous
3
2025
170
0.310
Why?
Injections, Intramuscular
3
2025
140
0.310
Why?
Female
23
2026
79080
0.300
Why?
Menstrual Cycle
1
2010
145
0.300
Why?
Prostatic Neoplasms
2
2026
972
0.300
Why?
Gender Identity
2
2021
132
0.290
Why?
Skull
1
2010
162
0.290
Why?
Hypothalamo-Hypophyseal System
2
2024
204
0.280
Why?
Male
22
2026
73014
0.280
Why?
Neurosecretory Systems
1
2007
31
0.250
Why?
Infertility
1
2007
61
0.250
Why?
Ovary
1
2008
235
0.230
Why?
Gonadotropin-Releasing Hormone
1
2007
215
0.230
Why?
Hypoparathyroidism
1
2025
7
0.230
Why?
Adult
16
2025
40821
0.230
Why?
Aged
10
2026
26251
0.210
Why?
Bone Remodeling
1
2024
71
0.210
Why?
Adrenal Insufficiency
1
2024
31
0.200
Why?
Thromboembolism
1
2024
129
0.190
Why?
Cohort Studies
2
2023
6045
0.180
Why?
Middle Aged
15
2026
36359
0.180
Why?
Brain Injuries
1
2007
499
0.170
Why?
Androgens
2
2013
179
0.160
Why?
Hydrocortisone
2
2024
303
0.160
Why?
Teriparatide
3
2025
10
0.160
Why?
Academic Medical Centers
1
2023
560
0.160
Why?
Hormones
1
2021
134
0.160
Why?
Osteitis Deformans
1
2020
9
0.150
Why?
Self Administration
1
2020
121
0.150
Why?
Osteolysis
1
2020
17
0.150
Why?
Dose-Response Relationship, Drug
1
2024
2018
0.150
Why?
Fractures, Compression
1
2020
21
0.150
Why?
Comprehensive Health Care
1
2019
24
0.150
Why?
Health Services for the Aged
1
2019
73
0.140
Why?
Self Report
1
2023
869
0.140
Why?
Bone and Bones
1
2021
318
0.140
Why?
Hip Fractures
1
2019
88
0.140
Why?
Pyrazoles
2
2013
516
0.140
Why?
House Calls
1
2020
154
0.140
Why?
Pyridines
2
2013
606
0.130
Why?
Spinal Stenosis
1
2018
31
0.130
Why?
Progesterone
1
2019
214
0.130
Why?
Anorexia Nervosa
1
2019
82
0.130
Why?
Back Pain
1
2018
56
0.130
Why?
Retrospective Studies
7
2025
17291
0.130
Why?
Anesthetics, Local
1
2018
106
0.130
Why?
Referral and Consultation
1
2023
878
0.130
Why?
Betacoronavirus
1
2020
288
0.130
Why?
HIV Infections
1
2012
3210
0.120
Why?
Pelvic Bones
1
2019
135
0.120
Why?
Aged, 80 and over
4
2023
8351
0.120
Why?
Curriculum
1
2023
1074
0.120
Why?
Protein Kinase Inhibitors
2
2013
982
0.120
Why?
Aging
1
2026
1983
0.110
Why?
Primary Health Care
2
2023
1768
0.110
Why?
Diagnosis, Differential
2
2011
1500
0.110
Why?
Sexual Behavior
1
2019
489
0.110
Why?
Adrenal Cortex Hormones
1
2018
483
0.110
Why?
Cardiovascular Diseases
1
2026
2218
0.100
Why?
Delivery of Health Care
1
2020
942
0.090
Why?
Surveys and Questionnaires
2
2023
6050
0.090
Why?
Hirsutism
1
2011
12
0.090
Why?
Pandemics
1
2020
1700
0.080
Why?
Quality of Life
2
2021
3187
0.080
Why?
Antineoplastic Agents
2
2013
2218
0.080
Why?
Injections, Intravenous
1
2010
197
0.080
Why?
Prevalence
2
2019
2852
0.080
Why?
Imidazoles
1
2010
244
0.070
Why?
Reference Values
1
2010
787
0.070
Why?
Chromatography, Liquid
1
2010
452
0.070
Why?
Pituitary Hormones
1
2008
15
0.070
Why?
Mycobacterium Infections, Nontuberculous
1
2012
339
0.070
Why?
Amenorrhea
1
2008
35
0.070
Why?
Kisspeptins
1
2007
5
0.070
Why?
Endocrine Glands
1
2007
14
0.060
Why?
Thyroid Hormones
1
2008
69
0.060
Why?
Tandem Mass Spectrometry
1
2010
574
0.060
Why?
Pituitary Hormones, Anterior
1
2007
7
0.060
Why?
Pituitary Gland, Anterior
1
2007
37
0.060
Why?
Prolactin
1
2007
88
0.060
Why?
Gonadal Steroid Hormones
1
2008
143
0.060
Why?
Hypothalamus
1
2007
161
0.060
Why?
Thyrotropin
1
2007
120
0.060
Why?
Carcinoma, Non-Small-Cell Lung
2
2013
1194
0.060
Why?
Adrenocorticotropic Hormone
1
2007
145
0.060
Why?
Incidence
1
2012
2910
0.060
Why?
Receptors, G-Protein-Coupled
1
2007
232
0.050
Why?
Calcitriol
1
2025
59
0.050
Why?
Tumor Suppressor Proteins
1
2007
314
0.050
Why?
Cross-Sectional Studies
3
2025
5875
0.050
Why?
Parathyroid Hormone
1
2025
118
0.050
Why?
Young Adult
3
2025
14240
0.050
Why?
Withholding Treatment
1
2024
77
0.050
Why?
Endocrinologists
1
2024
12
0.050
Why?
Lumbar Vertebrae
1
2024
259
0.050
Why?
Pituitary-Adrenal System
1
2024
169
0.050
Why?
Parathyroid Hormone-Related Protein
1
2022
25
0.050
Why?
Paroxetine
1
2000
8
0.040
Why?
Antidepressive Agents, Second-Generation
1
2000
44
0.040
Why?
Receptor Activator of Nuclear Factor-kappa B
1
2020
9
0.040
Why?
RANK Ligand
1
2020
29
0.040
Why?
Outpatient Clinics, Hospital
1
1999
80
0.040
Why?
Calcium
1
2025
1181
0.040
Why?
Nicotinic Agonists
1
2000
135
0.040
Why?
Double-Blind Method
3
2018
2064
0.040
Why?
Calcium, Dietary
1
2019
52
0.040
Why?
Health Status Indicators
1
1999
166
0.040
Why?
Drug Therapy, Combination
2
2018
1034
0.040
Why?
Tobacco Use Disorder
1
2000
217
0.030
Why?
Treatment Outcome
3
2025
11744
0.030
Why?
Triamcinolone
1
2018
13
0.030
Why?
Health Status
1
2024
822
0.030
Why?
Adolescent
2
2019
22451
0.030
Why?
Injections, Epidural
1
2018
28
0.030
Why?
Betamethasone
1
2018
21
0.030
Why?
Risk Factors
1
2012
10840
0.030
Why?
Methylprednisolone
1
2018
58
0.030
Why?
Lidocaine
1
2018
55
0.030
Why?
Nicotine
1
2000
334
0.030
Why?
United States
2
2025
16041
0.030
Why?
Vitamin D Deficiency
1
2019
188
0.030
Why?
Disease Progression
1
2024
2857
0.030
Why?
Smoking Cessation
1
2000
440
0.030
Why?
Eating
1
2019
386
0.030
Why?
Survival Analysis
1
2019
1372
0.030
Why?
Dexamethasone
1
2018
368
0.030
Why?
Estrogen Replacement Therapy
1
1996
144
0.030
Why?
Vitamin D
1
2019
402
0.030
Why?
Pain Measurement
1
2018
567
0.030
Why?
Body Composition
1
2019
686
0.030
Why?
Antibodies, Monoclonal
1
2022
1511
0.030
Why?
Pain Management
1
2018
413
0.030
Why?
Signal Transduction
1
2007
5234
0.020
Why?
Electronic Health Records
1
2022
1208
0.020
Why?
Biomarkers
1
2024
4329
0.020
Why?
Sex Hormone-Binding Globulin
1
2013
51
0.020
Why?
Funnel Chest
1
2012
31
0.020
Why?
Adipokines
1
2012
56
0.020
Why?
Serum Albumin
1
2013
147
0.020
Why?
Luteinizing Hormone
1
2013
206
0.020
Why?
Ethanol
1
1996
629
0.020
Why?
Follicle Stimulating Hormone
1
2013
265
0.020
Why?
Disease Susceptibility
1
2012
339
0.020
Why?
Scoliosis
1
2012
230
0.020
Why?
Alcohol Drinking
1
1996
847
0.020
Why?
Neoplasm Metastasis
1
2012
693
0.020
Why?
Adipose Tissue
1
2012
641
0.020
Why?
Patient Compliance
2
2000
587
0.010
Why?
Case-Control Studies
1
2012
3633
0.010
Why?
Colorectal Neoplasms
1
2013
870
0.010
Why?
Cytokines
1
2012
2079
0.010
Why?
Animals
1
2007
38030
0.010
Why?
Phenotype
1
2012
3186
0.010
Why?
Body Mass Index
1
2012
2446
0.010
Why?
Administration, Cutaneous
1
2000
127
0.010
Why?
Sampling Studies
1
1999
97
0.010
Why?
Sickness Impact Profile
1
1999
67
0.010
Why?
North Carolina
1
1999
127
0.010
Why?
Lung Neoplasms
1
2013
2674
0.010
Why?
Hospitals, Veterans
1
1999
256
0.010
Why?
Substance Withdrawal Syndrome
1
2000
184
0.010
Why?
Health Care Surveys
1
1999
538
0.010
Why?
Analysis of Variance
1
1999
1293
0.010
Why?
Medroxyprogesterone Acetate
1
1996
33
0.010
Why?
Cross-Over Studies
1
1996
612
0.010
Why?
Depression
1
2000
1566
0.000
Why?
Rothman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)